enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Chronic spontaneous urticaria - Wikipedia

    en.wikipedia.org/wiki/Chronic_spontaneous_urticaria

    Chronic spontaneous urticaria (CSU) also known as Chronic idiopathic urticaria (CIU) is defined by the presence of wheals, angioedema, or both for more than six weeks.The most common symptoms of chronic spontaneous urticaria are angioedema and hives that are accompanied by itchiness.

  3. Dupixent® (dupilumab) Phase 3 Trial Confirms Significant ...

    lite.aol.com/tech/story/0022/20240911/9228931.htm

    Outside of Japan, the safety and efficacy of Dupixent for CSU has not been fully evaluated by any regulatory authority. About Chronic Spontaneous Urticaria (CSU) CSU is a chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden and debilitating hives and persistent itch. CSU is typically treated with H1 ...

  4. Autoimmune urticaria - Wikipedia

    en.wikipedia.org/wiki/Autoimmune_urticaria

    The term autoimmune urticaria refers to a subset of chronic spontaneous urticaria (CSU) cases where the immune system appears to play a significant role. This understanding began to evolve in the mid to late 20th century as advances in immunology revealed the complex interactions between the immune system and various diseases.

  5. Ligelizumab - Wikipedia

    en.wikipedia.org/wiki/Ligelizumab

    Ligelizumab (INN; development code QGE031) is a humanized IgG1 monoclonal antibody designed for the treatment of severe asthma and chronic spontaneous urticaria. [1] It is an anti-IgE that binds to IGHE an acts as an immunomodulator. [2] [3] It is delivered as a subcutaneous biologic injection. [4] This drug was developed by Novartis Pharma AG.

  6. Press Release: Dupixent phase 3 study confirms significant ...

    lite.aol.com/tech/story/0022/20240911/1000991127.htm

    Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU . Confirming the results of CUPID-A, this second pivotal study in biologic-naïve patients met primary and key secondary endpoints, showing treatment with Dupixent resulted in a nearly 50% reduction in itch and urticaria activity scores compared to placebo

  7. Omalizumab - Wikipedia

    en.wikipedia.org/wiki/Omalizumab

    For example, a portion of the cases of chronic idiopathic urticaria [38] [39] and all cases of bullous pemphigoid [33] are clearly autoimmune diseases. For the remaining cases of chronic idiopathic urticaria and those of the different subtypes of physical urticaria, the internal abnormalities leading to the disease manifestation have not been ...

  8. Hives - Wikipedia

    en.wikipedia.org/wiki/Hives

    Hives including chronic spontaneous hives can be a complication and symptom of a parasitic infection, such as blastocystosis and strongyloidiasis among others. [11] The rash that develops from poison ivy, poison oak, and poison sumac contact is commonly mistaken for urticaria.

  9. Immunoglobulin E - Wikipedia

    en.wikipedia.org/wiki/Immunoglobulin_E

    Xolair has been approved in many countries for treating severe, persistent allergic asthma. It has also been approved in March 2014 in the European Union [36] and the U. S. [37] for treating chronic spontaneous urticaria, which cannot be adequately treated with H1-antihistamines. In the second approach, antibodies specific for a domain of 52 ...